TABLE 1. GLOBAL CANCER/TUMOR PROFILING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 2. GLOBAL CANCER/TUMOR PROFILING MARKET FOR NEXT-GENERATION SEQUENCING (NGS), BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL CANCER/TUMOR PROFILING MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL CANCER/TUMOR PROFILING MARKET FOR IMMUNOHISTOCHEMISTRY (IHC), BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL CANCER/TUMOR PROFILING MARKET FOR IN SITU HYBRIDIZATION (ISH), BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL CANCER/TUMOR PROFILING MARKET FOR FLUORESCENCE IN SITU HYBRIDIZATION (FISH), BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL CANCER/TUMOR PROFILING MARKET FOR CHROMOGENIC IN SITU HYBRIDIZATION (CISH), BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL CANCER/TUMOR PROFILING MARKET FOR MICROARRAY, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL CANCER/TUMOR PROFILING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL CANCER/TUMOR PROFILING MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 11. GLOBAL CANCER/TUMOR PROFILING MARKET FOR GENOMICS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL CANCER/TUMOR PROFILING MARKET FOR PROTEOMICS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL CANCER/TUMOR PROFILING MARKET FOR EPIGENETICS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL CANCER/TUMOR PROFILING MARKET FOR METABOLOMICS, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL CANCER/TUMOR PROFILING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL CANCER/TUMOR PROFILING MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL CANCER/TUMOR PROFILING MARKET FOR DIAGNOSTICS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL CANCER/TUMOR PROFILING MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2016-2023 ($MILLION)
TABLE 19. GLOBAL CANCER/TUMOR PROFILING MARKET FOR PROGNOSTICS, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL CANCER/TUMOR PROFILING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA CANCER/TUMOR PROFILING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA CANCER/TUMOR PROFILING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 24. NORTH AMERICA CANCER/TUMOR PROFILING MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE. NORTH AMERICA CANCER/TUMOR PROFILING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 26. EUROPE CANCER/TUMOR PROFILING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. EUROPE CANCER/TUMOR PROFILING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 28. EUROPE CANCER/TUMOR PROFILING MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 29. EUROPE CANCER VACCINES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 33. ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34. LAMEA CANCER/TUMOR PROFILING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. LAMEA CANCER/TUMOR PROFILING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 36. LAMEA CANCER/TUMOR PROFILING MARKET, BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 37. LAMEA CANCER/TUMOR PROFILING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 38. QIAGEN: COMPANY SNAPSHOT
TABLE 39. QIAGEN: OPERATING SEGMENTS
TABLE 40. ROCHE: COMPANY SNAPSHOT
TABLE 41. ROCHE: OPERATING SEGMENTS
TABLE 42. ABBOTT: COMPANY SNAPSHOT
TABLE 43. ABBOTT: OPERATING SEGMENTS
TABLE 44. ILLUMINA: COMPANY SNAPSHOT
TABLE 45. ILLUMINA: OPERATING SEGMENTS
TABLE 46. NEOGENOMICS: COMPANY SNAPSHOT
TABLE 47. ADURO: OPERATING SEGMENTS
TABLE 48. HTG: COMPANY SNAPSHOT
TABLE 49. HTG: OPERATING SEGMENTS
TABLE 50. GENOMIC HEALTH: COMPANY SNAPSHOT
TABLE 51. GENOMIC HEALTH: OPERATING SEGMENTS
TABLE 52. HOLOGIC: COMPANY SNAPSHOT
TABLE 53. HOLOGIC: OPERATING SEGMENTS
TABLE 54. BD: COMPANY SNAPSHOT
TABLE 55. BD: OPERATING SEGMENTS
TABLE 56. SIEMENS: COMPANY SNAPSHOT
TABLE 57. SIEMENS: OPERATING SEGMENTS
LIST OF FIGURE
FIGURE 1. GLOBAL CANCER/TUMOR PROFILING MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF CANCER/TUMOR PROFILING MARKET
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL CANCER/TUMOR PROFILING MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL CANCER/TUMOR PROFILING MARKET
FIGURE 13. U.S. CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 19. ITALY CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 20. SPAIN CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 22. JAPAN CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 23. CHINA CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE. AUSTRALIA CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 28. ARGENTINA CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 30. SOUTH AFRICA CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 31. REST OF LAMEA CANCER/TUMOR PROFILING MARKET, 2016-2023 ($MILLION)
FIGURE 32. QIAGEN: NET SALES, 2014-2016 ($MILLION)
FIGURE 33. QIAGEN: REVENUE BY SEGMENT, 2016 (%)
FIGURE 34. QIAGEN: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 35. ROCHE: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. ROCHE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 37. ROCHE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 38. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 39. ABBOTT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 40. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 41. ILLUMINA: NET SALES, 2014-2016 ($MILLION)
FIGURE 42. ILLUMINA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 43. ILLUMINA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 44. NEOGENOMICS: NET SALES, 2014-2016 ($MILLION)
FIGURE 45.NEOGENOMICS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 46. NEOGENOMICS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 47. HTG: NET SALES, 2014-2016 ($MILLION)
FIGURE 48. HTG: REVENUE BY SEGMENT, 2016 (%)
FIGURE 49. HTG: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 50. GENOMIC HEALTH: NET SALES, 2014-2016 ($MILLION)
FIGURE 51. GENOMIC HEALTH: REVENUE BY SEGMENT, 2016 (%)
FIGURE 52. GENOMIC HEALTH: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 53. HOLOGIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. HOLOGIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 55. HOLOGIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 56. BD: NET SALES, 2014-2016 ($MILLION)
FIGURE 57. BD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 58. BD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 59. SIEMENS: NET SALES, 2014-2016 ($MILLION)
FIGURE 60. SIEMENS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 61. SIEMENS: REVENUE BY GEOGRAPHY, 2016 (%)